Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas.

Clinical endocrinology - 1 Jan 2009

Jo Young Suk, Huang Songmei, Kim Yun-Jeung, Lee Ihn-Suk, Kim Song-Soo, Kim Je-Ryong, Oh Taejeong, Moon Youngho, An Sungwhan, Ro Heung-kyu, Kim Jin-Man, Shong Minho

Abstract excerpt

CONTEXT: Dideoxy sequencing is the most commonly used method for detecting the BRAF(V600E) mutation in thyroid cancer and melanoma. However, this gold standard method often makes less definite results in detecting the BRAF(V600E) mutation when there are relatively low amounts of the mutant template in biopsy specimens, which are invariably contaminated with normal tissues. Pyrosequencing, which measures the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Fine-Needle
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidental Findings

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Gland

Share to Thyroid Neoplasms

Share to Ultrasonography

Source

Identifiers

PMID: 18462259
DOI: 10.1111/j.1365-2265.2008.03293.x

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas.PMID 18462259Read ↗

Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules.Semantic proximity Read ↗

Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis.Semantic proximity Read ↗

Comparison Between Real-Time PCR and Pyrosequencing for Detection of BRAF V600E Mutation in Thyroid Fine-Needle Aspirates.Semantic proximity Read ↗

The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.Semantic proximity Read ↗

Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients.Semantic proximity Read ↗

BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.Semantic proximity Read ↗

Detection of RAS mutation by pyrosequencing in thyroid cytology samples.Semantic proximity Read ↗

Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.Semantic proximity Read ↗

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules.Semantic proximity Read ↗

BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay.Semantic proximity Read ↗

Clinical Implication of Highly Sensitive Detection of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules: A Comparative Analysis of Three Molecular Assays in 4585 Consecutive Cases in a BRAF V600E Mutation-Prevalent AreaSemantic proximity Read ↗

BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.